Disruption of the body's plantar fat pad can occur as a result of one of three mechanisms: simple fat pad atrophy associated with age-related degeneration, steroid use, or collagen vascular disease. Actual or relative displacement in to the underlying osseous prominences may be seen in association with structural deformity of the foot. Disease states such as diabetes may alter the normal structural integrity of soft tissues through nonenzymatic glycation leading to increased stiffness and thus reduced attenuating capacity. Fat pad atrophy, regardless of the cause, is often associated with substantial emotional, physical, productivity, and fnancial losses. In situations where the patient is sensate, the resultant skin on bone situation is extremely painful, especially when walking.
ChasanPE. The history of injectable silicone fluids for soft-tissue augmentation. Plast Reconstr Surg. 2007; 120 (7): 2034–40.
6.
OrentreichDLeoneAS. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone. Dermatol Surg. 2004; 30 (4 Pt 1): 548–51.
7.
AndrewsJM. Cellular behavior to injected silicone fluid: a preliminary report. Plast Reconstr Surg. 1966; 38 (6): 581–3.
8.
Ben-HurNBallantyneDLJrReesTDSeidmanI. Local and systemic effects of dimethylpolysiloxane fluid in mice. Plast Reconstr Surg. 1967; 39 (4): 423–6.
9.
NedelmanCI. Oral and cutaneous tissue reactions to injected fluid silicones. J Biomed Mater Res. 1968; 2 (1): 131–43.
10.
HawthorneGABallantyneDLJrReesTDSeidmanI. Hematological effects of dimethylpolysiloxane fluid in rats. J Reticuloendothel Soc. 1970; 7 (5): 587–93.
11.
BradleySGWhiteKLJrMcCayJABrownRDMusgroveDLWilsonSSternMLusterMIMunsonAE. Immunotoxicity of 180 day exposure to polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice. Drug Chem Toxicol. 1994; 17 (3): 221–69.
12.
BradleySGMunsonAEMcCayJABrownRDMusgroveDLWilsonSSternMLusterMIWhiteKLJr. Subchronic 10 day immunotoxicity of polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice. Drug Chem Toxicol. 1994; 17 (3): 175–220.
13.
KennedyGLJrKeplingerMLCalandraJC. Reproductive, teratologic, and mutagenic studies with some polydimethylsiloxanes. J Toxicol Environ Health. 1976; 1 (6): 909–20.
14.
WallaceWDBalkinSWKaplanLNelsonS. The histologic host response to liquid silicone injections for prevention of pressure-related ulcers of the foot: a 38-year study. J Am Podiatr Med Assoc. 2004; 94 (6): 550–7.
15.
BalkinSW. Injectable silicone and the foot: a 41-year clinical and histologic history. Dermatol Surg. 2005; 31 (11 Pt 2): 1555–9.
16.
AbouaeshaFvan SchieCHArmstrongDGBoultonAJ. Plantar soft-tissue thickness predicts high peak plantar pressure in the diabetic foot. J Am Podiatr Med Assoc. 2004; 94 (1): 39–42.
17.
AbouaeshaFvan SchieCHGriffthsGDYoungRJBoultonAJ. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care. 2001; 24 (7): 1270–4.
18.
BalkinSWReaTHKaplanL. Silicone oil prevention of insensitive pressure ulcers. Int J Lepr Other Mycobact Dis. 1997; 65 (3): 372–4.
19.
BalkinSWKaplanL. Silicone injection management of diabetic foot ulcers: a possible model for prevention of pressure ulcers. Decubitus. 1991; 4 (4): 38–40.
20.
BalkinSW. Silicone implants. J Am Podiatr Med Assoc. 1987; 77 (2): 104–5.
BalkinSW. Treatment of painful scars on soles and digits with injections of fluid silicone. J Dermatol Surg Oncol. 1977; 3 (6): 612–4.
23.
BalkinSW. Silicone augmentation for plantar calluses. J Am Podiatry Assoc. 1976; 66 (3): 148–54.
24.
BalkinSW. Treatment of corns by injectable silicone. Arch Dermatol. 1975; 111 (9): 1143–5.
25.
BalkinSW. Plantar keratoses: treatment by injectable liquid silicone. Report of an eight-year experience. Clin Orthop Relat Res. 1972; 87: 235–47.
26.
BalkinSW. Silicone injection for plantar keratoses. Preliminary report. J Am Podiatry Assoc. 1966; 56 (1): 1–11.
27.
Van SchieCHWhalleyAVileikyteLWignallTHollisSBoultonAJ. Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000; 23 (5): 634–8.
28.
Van SchieCHWhalleyAArmstrongDGVileikyteLBoultonAJ. The effect of silicone injections in the diabetic foot on peak plantar pressure and plantar tissue thickness: a 2-year follow-up. Arch Phys Med Rehabil. 2002; 83 (7): 919–23.
29.
TollafieldDRHoldcroftDJSinghRHaqueMS. Injectable percutaneous polydimethicone in the treatment of pedal keratomas: a single blind randomized trial. J Foot Ankle Surg. 2001; 40 (5): 295–301.
